INTERNATIONAL PATENT: UNIVERSITE DE FRANCHE-COMTE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, ETABLISSEMENT FRANÇAIS DU SANG, CENTRE HOSPITALIER UNIVERSITAIRE DE DIJON FILES APPLICATION FOR "METHYLATED BIOMARKERS FOR USE IN LUNG CANCER DIAGNOSIS"

GENEVA, July 2 -- UNIVERSITE DE FRANCHE-COMTE (1, rue Claude Goudimel25030 BESANCON CEDEX), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 PARIS), ETABLISSEMENT FRANÇAIS DU SANG (20 AVENUE DU STADE DE FRANCE93218 LA PLAINE SAINT-DENIS CEDEX), CENTRE HOSPITALIER UNIVERSITAIRE DE DIJON (P.O. Box BP 779081, boulevard Jeanne d'Arc21079 DIJON CEDEX) filed a patent application (PCT/EP2024/087953) for "METHYLATED BIOMARKERS FOR USE IN LUNG CANCER DIAGNOSIS" on Dec 20, 2024. With publication no. WO/2025/133153, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is manage...